Effects of gut microbiota on neurodegenerative diseases
暂无分享,去创建一个
[1] HuiChao Wang,et al. Changes in the Microbiota and their Roles in Patients with Type 2 Diabetes Mellitus , 2023, Current Microbiology.
[2] A. Lorentz,et al. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies. , 2023, Journal of applied microbiology.
[3] Emily K. Cope,et al. Predicting Neurodegenerative Disease Using Prepathology Gut Microbiota Composition: a Longitudinal Study in Mice Modeling Alzheimer’s Disease Pathologies , 2023, Microbiology spectrum.
[4] P. Roman,et al. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review , 2023, International journal of environmental research and public health.
[5] F. Cominelli,et al. A Novel Probiotic Combination Ameliorates Crohn's Disease-Like Ileitis by Increasing Short-Chain Fatty Acid Production and Modulating Essential Adaptive Immune Pathways. , 2023, Inflammatory bowel diseases.
[6] Li Zhang,et al. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. , 2023, Journal of ethnopharmacology.
[7] R. Pawliczak,et al. Does Oxidative Stress Along with Dysbiosis Participate in the Pathogenesis of Asthma in the Obese? , 2022, Cell Biochemistry and Biophysics.
[8] Beata Franczyk,et al. The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder , 2022, Nutrients.
[9] S. Askarova,et al. Gut microbiome alterations in Alzheimer’s patients from Kazakhstan , 2021, Alzheimer's & Dementia.
[10] L. McCullough,et al. Age-related immune alterations and cerebrovascular inflammation , 2021, Molecular Psychiatry.
[11] Guo Hu,et al. Host and microbiota metabolic signals in aging and longevity , 2021, Nature Chemical Biology.
[12] R. Bogacz,et al. Neural signatures of hyperdirect pathway activity in Parkinson’s disease , 2021, Nature Communications.
[13] A. El-Ansary,et al. Fecal Transplant and Bifidobacterium Treatments Modulate Gut Clostridium Bacteria and Rescue Social Impairment and Hippocampal BDNF Expression in a Rodent Model of Autism , 2021, Brain sciences.
[14] L. Vécsei,et al. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway , 2021, Biomedicines.
[15] L. Vécsei,et al. Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway , 2021, Biomedicines.
[16] Wei Chen,et al. Administration of Bifidobacterium breve Improves the Brain Function of Aβ1-42-Treated Mice via the Modulation of the Gut Microbiome , 2021, Nutrients.
[17] E. D. Khilazheva,et al. Blood–Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration , 2021, International journal of molecular sciences.
[18] P. Forsythe,et al. Vagotomy and insights into the microbiota-gut-brain axis , 2021, Neuroscience Research.
[19] K. Nelson,et al. Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls , 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[20] Xiaojun Wu,et al. Brain Neurotransmitter Modulation by Gut Microbiota in Anxiety and Depression , 2021, Frontiers in Cell and Developmental Biology.
[21] W. Banks,et al. Healthy aging and the blood–brain barrier , 2021, Nature Aging.
[22] Weihong Gu,et al. Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease , 2021, Frontiers in Immunology.
[23] F. Scheperjans,et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease , 2021, Molecular Neurodegeneration.
[24] C. Barbas,et al. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. , 2020, Journal of pharmaceutical and biomedical analysis.
[25] C. Huttenhower,et al. The human gut microbiota in people with amyotrophic lateral sclerosis , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[26] S. Burleigh,et al. Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease , 2020, Scientific Reports.
[27] Brittany D. Needham,et al. Gut microbial molecules in behavioural and neurodegenerative conditions , 2020, Nature Reviews Neuroscience.
[28] Jinxia Zhou,et al. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients , 2020, Scientific Reports.
[29] A. Hannan,et al. Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes , 2020, Brain communications.
[30] B. Vervliet,et al. Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial , 2020, Neuropsychopharmacology.
[31] I. Kaur,et al. Delivery routes for faecal microbiota transplants: Available, anticipated and aspired. , 2020, Pharmacological research.
[32] E. Elinav,et al. Interaction between microbiota and immunity in health and disease , 2020, Cell Research.
[33] E. Gatto,et al. Huntington disease: Advances in the understanding of its mechanisms☆ , 2020, Clinical parkinsonism & related disorders.
[34] H. Baik,et al. Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] Xuewei Zhu,et al. A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating microbiota-taurine-tight junction axis. , 2020, JCI insight.
[36] A. Hannan,et al. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease , 2020, Neurobiology of Disease.
[37] O. Koren,et al. The microbiota and the hypothalamus-pituitary-adrenocortical (HPA) axis, implications for anxiety and stress disorders , 2020, Current Opinion in Neurobiology.
[38] Hae Ung Lee,et al. Reprint of: Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease , 2020, Neurobiology of Disease.
[39] Ann M. Stowe,et al. Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms , 2019, The Journal of Neuroscience.
[40] J. Sonnenburg,et al. Vulnerability of the industrialized microbiota , 2019, Science.
[41] I. Mook‐Jung,et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model , 2019, Gut.
[42] Tianyu Gong,et al. Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice , 2019, Translational Psychiatry.
[43] W. Banks. The blood–brain barrier as an endocrine tissue , 2019, Nature Reviews Endocrinology.
[44] S. Carding,et al. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health , 2019, Gut microbes.
[45] H. Morita,et al. Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer’s disease , 2019, Bioscience, biotechnology, and biochemistry.
[46] R. Valdés-Mas,et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice , 2019, Nature Medicine.
[47] Junrong Du,et al. Probiotics modulate the microbiota–gut–brain axis and improve memory deficits in aged SAMP8 mice , 2019, Acta pharmaceutica Sinica. B.
[48] J. Hong,et al. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. , 2019, The Journal of nutritional biochemistry.
[49] E. Chuang,et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease , 2019, Journal of Neuroinflammation.
[50] M. Linterman,et al. Heterochronic faecal transplantation boosts gut germinal centres in aged mice , 2019, Nature Communications.
[51] J. Gilbert,et al. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes , 2019, The Journal of experimental medicine.
[52] T. Kuhara,et al. Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial. , 2019, Beneficial microbes.
[53] Vanni Bucci,et al. Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway , 2019, mBio.
[54] Chin-Hsien Lin,et al. Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease , 2019, Journal of movement disorders.
[55] L. Olofsson,et al. The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system , 2019, Journal of neuroendocrinology.
[56] Helen Y Wang,et al. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis , 2019, Journal of Neuroinflammation.
[57] Zein Al-Atrache,et al. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease , 2019, BMC Neuroscience.
[58] P. de Vos,et al. Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity , 2019, Scientific Reports.
[59] Su-Jin Jung,et al. Efficacy and Safety of Lactobacillus Plantarum C29-Fermented Soybean (DW2009) in Individuals with Mild Cognitive Impairment: A 12-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2019, Nutrients.
[60] A. Palloni,et al. Close social relationships correlate with human gut microbiota composition , 2019, Scientific Reports.
[61] A. Palloni,et al. Close social relationships correlate with human gut microbiota composition , 2019, Scientific Reports.
[62] S. Pongor,et al. Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome , 2019, Experimental Gerontology.
[63] L. Dargahi,et al. Probiotic mixture of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 attenuates hippocampal apoptosis induced by lipopolysaccharide in rats , 2018, International Microbiology.
[64] B. Lemaître,et al. Microbiota‐Derived Lactate Activates Production of Reactive Oxygen Species by the Intestinal NADPH Oxidase Nox and Shortens Drosophila Lifespan , 2018, Immunity.
[65] L. Dargahi,et al. The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model , 2018, Journal of the American College of Nutrition.
[66] J. Gostner,et al. Probiotic Supplementation in Patients with Alzheimer’s Dementia - An Explorative Intervention Study , 2018, Current Alzheimer research.
[67] Xiling Shen,et al. A gut-brain neural circuit for nutrient sensory transduction , 2018, Science.
[68] Bingdong Liu,et al. G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis , 2018, Front. Immunol..
[69] Dong-Hyun Kim,et al. Lactobacillus plantarum C29‐Fermented Soybean (DW2009) Alleviates Memory Impairment in 5XFAD Transgenic Mice by Regulating Microglia Activation and Gut Microbiota Composition , 2018, Molecular nutrition & food research.
[70] E. Zoetendal,et al. Age-dependent changes in GI physiology and microbiota: time to reconsider? , 2018, Gut.
[71] M. Salami,et al. Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial , 2018, Front. Neurol..
[72] L. Tan,et al. Innate immune activation in Alzheimer's disease. , 2018, Annals of translational medicine.
[73] Philip Strandwitz. Neurotransmitter modulation by the gut microbiota , 2018, Brain Research.
[74] M. Dubinsky,et al. Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease , 2018, JAMA neurology.
[75] Sterling C. Johnson,et al. THE GUT MICROBIOTA-DERIVED METABOLITE TRIMETHYLAMINE N-OXIDE (TMAO) IS ELEVATED IN ALZHEIMER’S DISEASE , 2018, Alzheimer's & Dementia.
[76] Luke R. Thompson,et al. Best practices for analysing microbiomes , 2018, Nature Reviews Microbiology.
[77] J. Viña,et al. Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan , 2018, Letters in applied microbiology.
[78] B. Racette,et al. Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries. , 2018, Parkinsonism & related disorders.
[79] Stuart M. Brown,et al. Parkinson’s disease and bacteriophages as its overlooked contributors , 2018, bioRxiv.
[80] M. Staufenbiel,et al. Innate immune memory in the brain shapes neurological disease hallmarks , 2018, Nature.
[81] M. Staufenbiel,et al. Innate immune memory in the brain shapes neurological disease hallmarks , 2018, Nature.
[82] M. Geschwind,et al. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. , 2018, Cold Spring Harbor perspectives in biology.
[83] L. Facci,et al. An Inflammation-Centric View of Neurological Disease: Beyond the Neuron , 2018, Front. Cell. Neurosci..
[84] A. Gould,et al. Early-life exposure to low-dose oxidants can increase longevity via microbiome remodelling in Drosophila , 2018, Nature Communications.
[85] A. Kurilshikov,et al. Environment dominates over host genetics in shaping human gut microbiota , 2018, Nature.
[86] M. Safa,et al. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1-42) injected rats. , 2018, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[87] Bruno Bonaz,et al. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis , 2018, Front. Neurosci..
[88] Matthew R Chapman,et al. The role of microbial amyloid in neurodegeneration , 2017, PLoS pathogens.
[89] Floor Hugenholtz,et al. Mouse models for human intestinal microbiota research: a critical evaluation , 2017, Cellular and Molecular Life Sciences.
[90] P. de Vos,et al. Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice , 2017, Front. Immunol..
[91] A. Khoruts,et al. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. , 2017, Archives of medical research.
[92] K. Abe,et al. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease , 2017, Scientific Reports.
[93] Luis Pedro Coelho,et al. Towards standards for human fecal sample processing in metagenomic studies , 2017, Nature Biotechnology.
[94] P. Caffarra,et al. The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid , 2017, Nutrients.
[95] F. Turroni,et al. Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients , 2017, Scientific Reports.
[96] Mallikarjuna Nimgampalle,et al. Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats. , 2017, Journal of clinical and diagnostic research : JCDR.
[97] Jin-Ju Jeong,et al. Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice , 2017, Mucosal Immunology.
[98] G. Rossi,et al. Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels , 2017, Scientific Reports.
[99] K. Suk,et al. Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis , 2017, Journal of the Neurological Sciences.
[100] S. Hazen,et al. Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects. , 2017, Circulation.
[101] M. Surette,et al. Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction , 2017, Cell host & microbe.
[102] I. Thiele,et al. Gut microbiota functions: metabolism of nutrients and other food components , 2017, European Journal of Nutrition.
[103] Patrick M. Smith,et al. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish , 2017, bioRxiv.
[104] A. Stagg,et al. Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota. , 2017, Inflammatory bowel diseases.
[105] D. D. Di Monte,et al. Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections , 2017, Acta Neuropathologica.
[106] C. Benoist,et al. Mining the Human Gut Microbiota for Immunomodulatory Organisms , 2017, Cell.
[107] G. Frisoni,et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota , 2017, Scientific Reports.
[108] Jun Sun,et al. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. , 2017, Clinical therapeutics.
[109] F. Bäckhed,et al. Role of gut microbiota in atherosclerosis , 2017, Nature Reviews Cardiology.
[110] T. Dinan,et al. Kynurenine pathway metabolism and the microbiota-gut-brain axis , 2017, Neuropharmacology.
[111] G. Frisoni,et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly , 2017, Neurobiology of Aging.
[112] E. Noble,et al. Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment , 2017, Front. Behav. Neurosci..
[113] C. Kraft,et al. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review , 2017, Gut microbes.
[114] E. Hsiao,et al. Interactions between the microbiota, immune and nervous systems in health and disease , 2017, Nature Neuroscience.
[115] T. Dinan,et al. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration , 2017, The Journal of physiology.
[116] Jianqiong Zhang,et al. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases , 2017, BMC Immunology.
[117] Rob Knight,et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.
[118] M. Salami,et al. Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial , 2016, Front. Aging Neurosci..
[119] Daniel H. Geschwind,et al. The Central Nervous System and the Gut Microbiome , 2016, Cell.
[120] Tingtao Chen,et al. Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing , 2016, Front. Microbiol..
[121] E. Cereda,et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease , 2016, Neurology.
[122] Xin Fang. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis , 2016, The International journal of neuroscience.
[123] K. Honda,et al. The microbiota in adaptive immune homeostasis and disease , 2016, Nature.
[124] H. Allen. Alzheimer’s Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-β with Regard to Potential Treatment and Prevention , 2016, Journal of Alzheimer's disease : JAD.
[125] R. Ratan,et al. Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? , 2016, Neuroscience Letters.
[126] Gonzalo Viana Di Prisco,et al. Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring , 2016, Cell.
[127] S. Rampelli,et al. Gut Microbiota and Extreme Longevity , 2016, Current Biology.
[128] G. O’Keeffe,et al. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. , 2016, Parkinsonism & related disorders.
[129] R. Osawa,et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study , 2016, BMC Microbiology.
[130] R. De Giorgio,et al. Enteroendocrine cells: a review of their role in brain–gut communication , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[131] J. Raes,et al. Population-level analysis of gut microbiome variation , 2016, Science.
[132] Alzheimer’s Association,et al. 2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.
[133] P. O’Toole,et al. Gut microbiota and aging , 2015, Science.
[134] X. Wu,et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress , 2015, Neuroscience.
[135] Meng Zhang,et al. A study on the association between infectious burden and Alzheimer's disease , 2015, European journal of neurology.
[136] B. Bonaz,et al. Brain-gut-microbiota axis in Parkinson's disease. , 2015, World journal of gastroenterology.
[137] R. Catanzaro,et al. The gut microbiota and its correlations with the central nervous system disorders. , 2015, Panminerva medica.
[138] Ali Keshavarzian,et al. Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[139] M. Pellegrini,et al. Distinct Shifts in Microbiota Composition during Drosophila Aging Impair Intestinal Function and Drive Mortality. , 2015, Cell reports.
[140] M. Sun,et al. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota , 2015, Mucosal Immunology.
[141] H. D. Rosas,et al. A systems-level “misunderstanding”: the plasma metabolome in Huntington’s disease , 2015, Annals of clinical and translational neurology.
[142] Wei Li,et al. Beneficial Microbes , 2015 .
[143] Jun Sun,et al. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model , 2015, Physiological reports.
[144] F. Rey,et al. Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.
[145] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[146] G. Sellge,et al. PRR-signaling pathways: Learning from microbial tactics. , 2015, Seminars in immunology.
[147] W. Lukiw,et al. Microbial-generated amyloids and Alzheimer's disease (AD) , 2015, Front. Aging Neurosci..
[148] T. Dinan,et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.
[149] Renshi Xu,et al. An Astrocyte Regenerative Response from Vimentin-Containing Cells in the Spinal Cord of Amyotrophic Lateral Sclerosis's Disease-Like Transgenic (G93A SOD1) Mice , 2015, Neurodegenerative Diseases.
[150] M. Harrington. For lack of gut microbes, the blood–brain barrier 'leaks' , 2014, Lab Animal.
[151] J. Koenig,et al. Microbial shifts in the aging mouse gut , 2014, Microbiome.
[152] N. Pomara,et al. A review of the relationship between proinflammatory cytokines and major depressive disorder. , 2014, Journal of affective disorders.
[153] Lai Guan Ng,et al. The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.
[154] Yang Yang,et al. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β. , 2014, Journal of Alzheimer's disease : JAD.
[155] R. Flavell,et al. Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota. , 2014, International immunology.
[156] A. Kuwahara. Contributions of Colonic Short-Chain Fatty Acid Receptors in Energy Homeostasis , 2014, Front. Endocrinol..
[157] S. Fijan. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature , 2014, International journal of environmental research and public health.
[158] Jimmy D Bell,et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism , 2014, Nature Communications.
[159] D. Turnbull,et al. Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?☆ , 2014, Ageing Research Reviews.
[160] P. Sanberg,et al. Blood-CNS Barrier Impairment in ALS patients versus an animal model , 2014, Front. Cell. Neurosci..
[161] R. Ransohoff,et al. Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.
[162] Barbara M. Bakker,et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.
[163] W. Garrett,et al. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.
[164] S. Akira,et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. , 2013, Immunity.
[165] P. Scully,et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner , 2013, Molecular Psychiatry.
[166] M. Shinohara,et al. The role of interferon‐β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis – in the perspective of inflammasomes , 2013, Immunology.
[167] A. Tagliabue,et al. The role of gut microbiota in human obesity: recent findings and future perspectives. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[168] F. Bäckhed,et al. The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.
[169] Blaise R. Boles,et al. Microbial amyloids--functions and interactions within the host. , 2013, Current opinion in microbiology.
[170] Nicholas Stoy,et al. An expanding range of targets for kynurenine metabolites of tryptophan. , 2013, Trends in pharmacological sciences.
[171] J. Bienenstock,et al. On communication between gut microbes and the brain , 2012, Current opinion in gastroenterology.
[172] S. Bengmark. Gut microbiota, immune development and function. , 2012, Pharmacological research.
[173] T. Dinan,et al. Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .
[174] R. Knight,et al. Diversity, stability and resilience of the human gut microbiota , 2012, Nature.
[175] P. O’Toole,et al. γ‐Aminobutyric acid production by culturable bacteria from the human intestine , 2012, Journal of applied microbiology.
[176] R. Schwarcz,et al. Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.
[177] Blaise R. Boles,et al. Functional Amyloids Composed of Phenol Soluble Modulins Stabilize Staphylococcus aureus Biofilms , 2012, PLoS pathogens.
[178] F. Mégraud,et al. Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results , 2012, Neurobiology of Aging.
[179] J. Clemente,et al. Human gut microbiome viewed across age and geography , 2012, Nature.
[180] R. Oozeer,et al. The early settlers: intestinal microbiology in early life. , 2012, Annual review of food science and technology.
[181] O. Suchowersky,et al. Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg? , 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[182] N. Floc’h,et al. Tryptophan metabolism, from nutrition to potential therapeutic applications , 2011, Amino Acids.
[183] John F. Cryan,et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve , 2011, Proceedings of the National Academy of Sciences.
[184] M. Mintun,et al. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans , 2011, Proceedings of the National Academy of Sciences.
[185] J. Gordon,et al. Human nutrition, the gut microbiome and the immune system , 2011, Nature.
[186] Pierre J Magistretti,et al. Labeled Acetate as a Marker of Astrocytic Metabolism , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[187] P. Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[188] Rob Knight,et al. The mind-body-microbial continuum , 2011, Dialogues in clinical neuroscience.
[189] H. Forssberg,et al. Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.
[190] G. MacQueen,et al. Bacterial infection causes stress-induced memory dysfunction in mice , 2010, Gut.
[191] N. Van Rooijen,et al. Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease , 2010, Journal of neurochemistry.
[192] Marcus J. Claesson,et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly , 2010, Proceedings of the National Academy of Sciences.
[193] P. Klivényi,et al. The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection , 2009, Journal of the Neurological Sciences.
[194] B. Brew,et al. Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons , 2009, Neurotoxicity Research.
[195] W. Cefalu,et al. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.
[196] W. R. Wikoff,et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.
[197] M. Tsolaki,et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease , 2009, Journal of Neurology.
[198] L. Desbonnet,et al. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. , 2008, Journal of psychiatric research.
[199] Bruce Fischl,et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. , 2008, Brain : a journal of neurology.
[200] B. Brew,et al. The involvement of astrocytes and kynurenine pathway in Alzheimer’s disease , 2007, Neurotoxicity Research.
[201] D. Jonkers,et al. Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.
[202] Yoshifumi Oshima,et al. Dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet , 2006, British Journal of Nutrition.
[203] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[204] S. Augood,et al. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease , 2004, Neurobiology of Disease.
[205] M. Nedergaard,et al. The blood–brain barrier: an overview Structure, regulation, and clinical implications , 2004, Neurobiology of Disease.
[206] A. Fasano,et al. Gastrointestinal dysfunction in Parkinson's disease , 2003, The Lancet Neurology.
[207] Hanns Lochmüller,et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. , 1997, European journal of medical research.
[208] M. Beal,et al. Kynurenine pathway abnormalities in Parkinson's disease , 1992, Neurology.
[209] D. Jenkins,et al. Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. , 1991, The American journal of clinical nutrition.
[210] B. Wostmann,et al. Aging in germ-free mice: life tables and lesions observed at natural death. , 1966, Journal of gerontology.
[211] K. B. Bach Knudsen. Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health. , 2015, Advances in nutrition.
[212] R. Daneman,et al. The blood-brain barrier. , 2015, Cold Spring Harbor perspectives in biology.
[213] J. Bienenstock,et al. Vagal pathways for microbiome-brain-gut axis communication. , 2014, Advances in experimental medicine and biology.
[214] L. Gioglio,et al. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? , 2014, Journal of Alzheimer's disease : JAD.
[215] W. D. de Vos,et al. Contribution of the intestinal microbiota to human health: from birth to 100 years of age. , 2013, Current topics in microbiology and immunology.
[216] Samuel I. Miller,et al. LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.
[217] D. Fuchs,et al. Tryptophan degradation and immune activation in Alzheimer's disease , 2000, Journal of Neural Transmission.